{"news":[{"title":"Stellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting","published":"2016-03-29 17:00:00"},{"title":"Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange","published":"2016-03-23 08:30:00"},{"title":"Stellar Biotechnologies to Present at the 28th Annual ROTH Conference","published":"2016-03-09 08:30:00"},{"title":"Stellar Biotechnologies Reports First Quarter 2016 Financial Results and Operational Highlights","published":"2016-02-08 16:15:00"},{"title":"Stellar Biotechnologies Announces First Quarter 2016 Corporate Update Conference Call","published":"2016-02-04 08:30:00"},{"title":"Stellar Biotechnologies Presents Research on Nanofiltration Development at PepTalk Conference","published":"2016-01-26 08:30:00"},{"title":"Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)","published":"2016-01-20 16:00:00"},{"title":"Stellar Biotechnologies to Present at Biotech Showcase 2016 Conference","published":"2016-01-08 08:30:00"},{"title":"Stellar Biotechnologies Reports Fiscal Year-End 2015 Financial Results and Operational Highlights","published":"2015-12-14 16:30:00"},{"title":"Stellar Biotechnologies Announces Year-End 2015 Corporate Update Conference Call","published":"2015-12-10 12:30:00"},{"title":"Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Research at Society for Glycobiology Meeting","published":"2015-12-04 08:30:00"},{"title":"Stellar Biotechnologies to Present at LD Micro Main Event","published":"2015-11-24 08:30:00"},{"title":"Stellar Biotechnologies Commences Trading on NASDAQ","published":"2015-11-05 08:30:00"},{"title":"Stellar Biotechnologies Announces Approval of NASDAQ Uplisting","published":"2015-11-03 16:15:00"},{"title":"Stellar Biotechnologies Announces Results of Special Meeting of Shareholders","published":"2015-10-29 15:04:00"},{"title":"Stellar Biotechnologies Issues Corporate Update","published":"2015-10-23 08:30:00"},{"title":"Stellar Biotechnologies to Participate in 6th BioMarine International Business Convention","published":"2015-10-07 08:30:00"},{"title":"Stellar Biotechnologies and Amaran Biotechnology Provide Update on Collaboration","published":"2015-10-01 08:30:00"},{"title":"Stellar Biotechnologies' Partner Neovacs Reports Potent and Long-Lasting Biological Activity of IFN-Alpha-Kinoid Immunotherapy 4 Years After Patient Dosing in Lupus Phase I\/IIa Trial","published":"2015-09-17 08:30:00"},{"title":"Stellar Biotechnologies Provides Update on Anticipated Listing on the NASDAQ Capital Market and Announces Meeting and Record Date for the Special Meeting of Shareholders on October 29, 2015","published":"2015-09-15 08:30:00"},{"title":"CORRECTION TO STOCK SYMBOL - Stellar Biotechnologies Announces Reverse Stock Split Effective September 2, 2015","published":"2015-09-02 11:30:00"},{"title":"Stellar Biotechnologies Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market","published":"2015-08-28 08:30:00"},{"title":"Stellar Biotechnologies Reports Third Quarter 2015 Financial Results and Operational Highlights","published":"2015-08-10 08:30:00"},{"title":"Stellar Biotechnologies Signs Collaboration Agreement to Expand KLH Aquaculture Operations","published":"2015-07-28 08:30:00"},{"title":"Stellar Biotechnologies Retains The Ruth Group to Advance Communications Objectives","published":"2015-07-09 08:30:00"},{"title":"Stellar Biotechnologies to Present at 5thAnnual LD Micro Invitational","published":"2015-06-01 08:30:00"},{"title":"Stellar Biotechnologies to Present at 2015 Marcum MicroCap Conference","published":"2015-05-27 08:30:00"},{"title":"Stellar Biotechnologies' Immunology 2015 Poster Available Online","published":"2015-05-15 08:30:00"},{"title":"Stellar Biotechnologies Expands Online Corporate Communications Channels","published":"2015-05-14 08:30:00"},{"title":"Stellar Biotechnologies Reports Second Quarter 2015 Financial Results","published":"2015-05-11 16:30:00"},{"title":"Stellar Biotechnologies Presents Poster at Immunology 2015 on the Immunogenicity of Different Forms and Preparations of KLH","published":"2015-04-30 08:30:00"},{"title":"Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationship","published":"2015-04-01 02:00:00"},{"title":"First FDA Breakthrough Therapy Designation for KLH-Conjugate Immunotherapy Signals Key Step for Novel Carrier Molecule","published":"2015-03-10 17:31:00"},{"title":"Stellar Biotechnologies Reports First Quarter 2015 Financial Results","published":"2015-02-09 08:30:00"},{"title":"Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference","published":"2015-01-08 08:30:00"},{"title":"Stellar Biotechnologies to Present at LD Micro Conference","published":"2014-11-24 08:30:00"},{"title":"Stellar Biotechnologies Reports Year-End 2014 Financial Results","published":"2014-11-13 10:16:00"},{"title":"Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies","published":"2014-11-11 12:43:00"},{"title":"Stellar Biotechnologies Announces Resignation of CTO Effective December 10, 2014","published":"2014-11-07 13:30:00"},{"title":"Stellar Biotechnologies Announces Year-End 2014 Conference Call","published":"2014-11-06 08:30:00"},{"title":"Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma","published":"2014-10-23 14:14:00"},{"title":"Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference","published":"2014-09-02 12:02:00"},{"title":"Stellar Biotechnologies Reports on Unusual Trading Activity","published":"2014-08-29 08:30:00"},{"title":"Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments","published":"2014-07-10 08:30:00"},{"title":"Stellar Biotechnologies Appoints Two Members to Scientific Advisory Board","published":"2014-06-06 08:30:00"},{"title":"Stellar Biotechnologies Releases Corporate Video","published":"2014-05-20 08:30:00"},{"title":"Stellar Biotechnologies to Present at Two Upcoming Conferences","published":"2014-05-15 08:30:00"},{"title":"Stellar Biotechnologies Retains Stonegate for Institutional Outreach","published":"2014-05-07 08:30:00"},{"title":"Stellar Biotechnologies Launches New Corporate Website","published":"2014-05-02 08:00:00"},{"title":"Stellar Biotechnologies Reports Second Quarter 2014 Financial Results and Recent Corporate Developments","published":"2014-04-10 09:00:00"},{"title":"Stellar Biotechnologies to Host Corporate Update and Second Quarter 2014 Results Conference Call on April 10","published":"2014-04-04 09:00:00"},{"title":"Stellar Biotechnologies Presenting Today at 2014 TSX Venture 50(R) Spotlight Event","published":"2014-04-01 09:00:00"},{"title":"Stellar Biotechnologies Presents Poster on KLH Achievements at Gordon Research Conference","published":"2014-03-03 09:05:00"},{"title":"Stellar Biotechnologies to Present at the 26th Annual ROTH Capital Growth Conference","published":"2014-02-27 09:05:00"},{"title":"Stellar Biotechnologies Reports on Annual General and Special Meeting","published":"2014-02-18 09:05:00"},{"title":"Stellar Biotechnologies Named 2014 TSX Venture 50(R) Company","published":"2014-02-13 09:05:00"},{"title":"Stellar Biotechnologies Presents KLH Verification Method at Aquaculture America Conference","published":"2014-02-12 09:05:00"},{"title":"Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January","published":"2014-01-06 09:05:00"},{"title":"Stellar Biotechnologies Issues Year-End Results and Highlights From 2013","published":"2014-01-02 09:05:00"},{"title":"Stellar Biotechnologies, Inc. Announces Meeting and Record Date and Approval of Advance Notice Policy","published":"2013-12-27 16:00:00"},{"title":"Stellar Biotechnologies Announces Collaboration With Amaran Biotechnology, Inc.","published":"2013-12-12 12:01:00"},{"title":"Stellar Biotechnologies Announces Patents for Clostridium Difficile Immunotherapy Technology Issued in U.S. and China","published":"2013-12-09 09:05:00"},{"title":"Stellar Biotechnologies to Host Corporate Update Conference Call and Webcast on December 11","published":"2013-12-03 09:05:00"},{"title":"Stellar Biotechnologies to Present at 6th Annual LD Micro Conference December 4, 2013","published":"2013-11-25 09:05:00"},{"title":"Stellar Biotechnologies Appoints Mark A. McPartland as Vice President of Corporate Development and Communications","published":"2013-11-20 09:05:00"},{"title":"Stellar Biotechnologies Expands Senior Leadership Roles With Two Key Appointments","published":"2013-11-05 09:05:00"},{"title":"Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Active Immunotherapy at Vaccine Congress","published":"2013-10-28 09:05:00"},{"title":"Stellar Biotechnologies Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study","published":"2013-10-21 09:05:00"},{"title":"Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors","published":"2013-09-25 09:05:00"},{"title":"Stellar Biotechnologies Closes US$12 Million Private Placement Financing","published":"2013-09-23 09:05:00"},{"title":"Stellar Biotechnologies Raises US$10 Million in Initial Closing of Private Placement","published":"2013-09-10 14:59:00"},{"title":"Stellar Biotechnologies to Present at Rodman and Renshaw 13th Annual Global Investment Conference From September 8-10, 2013","published":"2013-08-29 09:05:00"},{"title":"Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement","published":"2013-08-22 09:05:00"},{"title":"Stellar Biotechnologies Issues President's Letter to Shareholders","published":"2013-08-06 09:05:00"},{"title":"Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology","published":"2013-07-30 09:05:00"},{"title":"Stellar Biotechnologies Announces Joint Research on Clostridium Difficile Immunotherapy Accepted for Presentation","published":"2013-07-24 18:01:00"},{"title":"Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference","published":"2013-05-28 09:00:00"},{"title":"Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference","published":"2013-05-21 09:33:00"},{"title":"Stellar Biotechnologies Announces Publication of \"Expert Review\" Article on Clostridium Difficile Vaccines","published":"2013-04-30 09:00:00"},{"title":"Stellar Biotechnologies Submits Biological Master File to U.S. FDA for Subunit KLH","published":"2013-03-19 09:15:00"},{"title":"Stellar Biotechnologies Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter","published":"2013-03-13 09:10:00"},{"title":"Stellar Biotechnologies Exceeds Aquaculture Capacity Goals","published":"2013-02-19 08:05:00"},{"title":"Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations","published":"2013-02-06 10:36:00"},{"title":"Stellar Biotechnologies Pioneers Aquaculture Milestone in KLH Protein Manufacturing","published":"2013-01-22 08:55:00"},{"title":"Stellar Biotechnologies to Present at Nobel Financial Capital Markets Ninth Annual Equity Conference January 23, 2013","published":"2013-01-17 09:35:00"},{"title":"Stellar Biotechnologies' Shares Begin Trading on the OTCQB Market","published":"2013-01-15 13:43:00"},{"title":"Stellar Biotechnologies to Present at Biotech Showcase(TM) in San Francisco on January 7th, 2013","published":"2013-01-02 10:15:00"},{"title":"Stellar Biotechnologies, Inc. to Host Conference Call at 2:30 pm ET on Tuesday, December 18, 2012 to Provide Business Overview","published":"2012-12-12 09:05:00"},{"title":"Stellar Biotechnologies Files U.S. Patent Application for KLH Manufacturing Innovations","published":"2012-12-04 08:55:00"},{"title":"Stellar Biotechnologies to Present at LD Micro Conference in Los Angeles on December 5th, 2012","published":"2012-11-27 09:05:00"},{"title":"Stellar Biotechnologies Announces Filing a US Letters Patent Application","published":"2012-10-04 15:19:00"},{"title":"Stellar Biotechnologies Presented at World Congress of Marine Biotechnology","published":"2012-09-26 09:45:00"},{"title":"Stellar Biotechnologies to Present at ImVacS 2012 Summit on August 13-16, 2012","published":"2012-06-25 10:55:00"},{"title":"Stellar Biotechnologies to Present at ICAAC 2012 Conference on September 9 - 12, 2012","published":"2012-06-20 09:05:00"},{"title":"Stellar Biotechnologies Launches KLH Site(TM)","published":"2012-04-25 10:47:00"},{"title":"Stellar Biotechnologies Announces Exclusive Option to License Clostridium Difficile Technology","published":"2012-04-10 09:05:00"},{"title":"Stellar Biotechnologies Launches Stellar KLH(TM) ELISA Test Kits","published":"2012-04-03 09:05:00"},{"title":"Stellar Biotechnologies Publishes New Corporate Profile","published":"2012-03-13 09:00:00"},{"title":"Stellar Biotechnologies Announces Investor Relations Agreement","published":"2012-01-18 09:20:00"},{"title":"Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations","published":"2012-01-04 09:10:00"}]}